|
Volumn 12, Issue 3, 2003, Pages 37-40
|
Metabolic syndrome: What is it and how should i treat it?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
CHOLESTEROL;
FATTY ACID;
FIBRIC ACID DERIVATIVE;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LOW DENSITY LIPOPROTEIN;
METFORMIN;
THIAZOLIDINE DERIVATIVE;
TRIACYLGLYCEROL;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
DIAGNOSTIC TEST;
DRUG EFFICACY;
DYSLIPIDEMIA;
FATTY ACID BLOOD LEVEL;
GASTROINTESTINAL HEMORRHAGE;
GENETIC SUSCEPTIBILITY;
GLUCOSE BLOOD LEVEL;
HEALTH PROGRAM;
HIGH RISK PATIENT;
HUMAN;
IMMOBILIZATION;
INSULIN BLOOD LEVEL;
ISCHEMIC HEART DISEASE;
LIFESTYLE;
LOW DRUG DOSE;
METABOLIC DISORDER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PHYSICAL ACTIVITY;
REVIEW;
RISK FACTOR;
TRIACYLGLYCEROL BLOOD LEVEL;
UNITED STATES;
WEIGHT REDUCTION;
|
EID: 0038387952
PISSN: 10621458
EISSN: None
Source Type: Journal
DOI: 10.1016/S1062-1458(03)00225-3 Document Type: Review |
Times cited : (4)
|
References (0)
|